Back to search
FDAFDA · Food and drugs·Recall number D-1296-2014

Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30 count bottle, OTC Manufactured by Sun Pharma, Gujarat, India, NDC 47335-343-83

Published May 7, 2014 · Recall initiated: April 9, 2014

Summary

FDA records drug Class III recall D-1296-2014, published May 7, 2014 and initiated April 9, 2014. Recalling firm: Caraco Pharmaceutical Laboratories, Ltd.; Status: Terminated; Reported quantity: 128,363 bottles; Lot: JKM2067A Exp. 07/14, JKM2068A Exp.10/14, JKM2069A Exp. 01/15, JKM6399A Exp. 04/15. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Caraco Pharmaceutical Laboratories, Ltd.
Distributor
Nationwide
Lot
JKM2067A Exp. 07/14, JKM2068A Exp.10/14, JKM2069A Exp. 01/15, JKM6399A Exp. 04/15
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30 count bottle, OTC Manufactured by Sun Pharma, Gujarat, India, NDC 47335-343-83 recalled?

Yes. FDA published recall D-1296-2014 on May 7, 2014. Reported hazard: Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit